LianBio ADR (NASDAQ:LIAN) shares, rose in value, with the stock price up by 83.05% to the previous day’s close as strong demand from buyers drove the stock to $0.35.
Actively observing the price movement in the last trading, the stock closed the session at $0.19. The value of beta (5-year monthly) was 0.23. Referring to stock’s 52-week performance, its high was $0.19, and the low was $0.05. On the whole, LIAN has fluctuated by 91.90% over the past month.
With the market capitalization of LianBio ADR currently standing at about $37.27 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 25, 2024 – Mar 29, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.31, which is expected to increase to -$0.09 for fiscal year -$0.84 and then to about -$0.85 by fiscal year 2024. Data indicates that the EPS growth is expected to be 17.60% in 2024, while the next year’s EPS growth is forecast to be -1.20%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that LIAN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of LIAN currently trading nearly 87.82% and 104.86% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 97.35, while the 7-day volatility ratio is showing 9.57% which for the 30-day chart, stands at 2.93%. Furthermore, LianBio ADR (LIAN)’s beta value is 0.23, and its average true range (ATR) is 0.02.
A comparison of LianBio ADR (LIAN) with its peers suggests the former has fared considerably weaker in the market. LIAN showed an intraday change of 83.05% in last session, and over the past year, it grew by 448.61%%.
Data on historical trading for LianBio ADR (NASDAQ:LIAN) indicates that the trading volumes over the past 10 days have averaged 2.58 million and over the past 3 months, they’ve averaged 14.37 million. According to company’s latest data on outstanding shares, there are 107.04 million shares outstanding.
Nearly 2.24% of LianBio ADR’s shares belong to company insiders and institutional investors own 76.65% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.38 million shares as on Feb 29, 2024, resulting in a short ratio of 0.4. According to the data, the short interest in LianBio ADR (LIAN) stood at 0.35% of shares outstanding as of Feb 29, 2024; the number of short shares registered in Jan 31, 2024 reached 0.23 million. The stock has risen by 104.35% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LIAN stock heading into the next quarter.
